RSI low/high Values: [ 25 - 75 ]
* uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MDXG
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy

MiMedx Group stock price up 3.35% on Monday
(Updated on Jul 22, 2024)

Buy candidate since Jul 10, 2024 Gain 8.03% PDF

The MiMedx Group stock price gained 3.35% on the last trading day (Monday, 22nd Jul 2024), rising from $7.16 to $7.40. During the last trading day the stock fluctuated 3.41% from a day low at $7.18 to a day high of $7.43. The price has risen in 6 of the last 10 days and is up by 8.66% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 65 thousand more shares were traded than the day before. In total, 439 thousand shares were bought and sold for approximately $3.25 million.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect MiMedx Group stock with a 90% probability to be traded between $6.54 and $7.87 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MDXG Signals & Forecast

Mostly positive signals in the chart today. The MiMedx Group stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $7.29 and $7.00. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 26, 2024, and so far it has risen 10.94%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for MiMedx Group stock

MiMedx Group finds support from accumulated volume at $7.31 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.245 between high and low, or 3.41%. For the last week, the stock has had daily average volatility of 3.49%.

Our recommended stop-loss: $7.14 (-3.50%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 45 days ago.)

Trading Expectations (MDXG) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect MiMedx Group to open at $7.34, and during the day (based on 14 day Average True Range), to move between $7.18 and $7.62, which gives a possible trading interval of +/-$0.223 (+/-3.02%) up or down from last closing price. If MiMedx Group takes out the full calculated possible swing range there will be an estimated 6.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $7.31 (1.22%) than the resistance at $7.50 (1.35%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MiMedx Group stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for MiMedx Group stock to perform well in the short-term period.

Current score: 1.910 Buy Candidate Unchanged

Predicted Opening Price for MiMedx Group of Tuesday, July 23, 2024

Fair opening price July 23, 2024 Current price
$7.34 ( 0.88%) $7.40

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MDXG

Fibonacci Support & Resistance Levels

Level Price
R3 7.58 2.43%
R2 7.49 1.17%
R1 7.43 0.386%
Price 7.40
S1 7.24 -2.14%
S2 7.18 -2.92%
S3 7.09 -4.19%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.90 6.76%
R2 7.51 1.49%
R1 7.50 1.35%
Price 7.40
S1 7.31 -1.22%
S2 6.93 -6.35%
S3 6.87 -7.16%


What is the symbol for MiMedx Group Stock and on which exchange is it traded?
The symbol for MiMedx Group is MDXG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MiMedx Group Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for MiMedx Group stock to perform well in the short-term period.

How to buy MiMedx Group Stock?
MiMedx Group Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MiMedx Group Stock.

What's the current price of MiMedx Group Stock?
As of the end of day on the Jul 22, 2024, the price of an MiMedx Group (MDXG) share was $7.40.

What is the 52-week high and low for MiMedx Group Stock?
The 52-week high for MiMedx Group Stock is $9.27 and the 52-week low is $5.57.

What is the market capitalization of MiMedx Group Stock?
As of the Jul 22, 2024, the market capitalization of MiMedx Group is 1.092B.

When is the next earnings date for MiMedx Group?
The upcoming earnings date for MiMedx Group is Jul 31, 2024.
Click to get the best stock tips daily for free!

About MiMedx Group

MiMedx Group MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its produc... MDXG Profile

Top Fintech Company featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE